Baotou Dongbao Bio-Tech Co Ltd (300239) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.005x

Based on the latest financial reports, Baotou Dongbao Bio-Tech Co Ltd (300239) has a cash flow conversion efficiency ratio of 0.005x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥8.19 Million ≈ $1.20 Million USD) by net assets (CN¥1.69 Billion ≈ $247.61 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market value of Baotou Dongbao Bio-Tech Co Ltd for the company's overall valuation and market capitalisation.

Baotou Dongbao Bio-Tech Co Ltd - Cash Flow Conversion Efficiency Trend (2008–2025)

This chart illustrates how Baotou Dongbao Bio-Tech Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Baotou Dongbao Bio-Tech Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Baotou Dongbao Bio-Tech Co Ltd ranked by their cash flow conversion efficiency. Explore 300239 cash flow quality score to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Testa Residencial SOCIMI S.A. MC:YTST	N/A
Eurocrane China Co Ltd SHG:603966	0.072x
Raymond Lifestyle Ltd NSE:RAYMONDLSL	-0.012x
Vinh Hoan Corp VN:VHC	-0.038x
MiCo Ltd KQ:059090	0.027x
ZheJiang Haers Vacuum Containers Co Ltd SHE:002615	0.076x
Nanning Department Store Co Ltd SHG:600712	0.000x
Zhongxing Shenyang Commercial Building Group Co Ltd SHE:000715	0.029x

Annual Cash Flow Conversion Efficiency for Baotou Dongbao Bio-Tech Co Ltd (2008–2025)

The table below shows the annual cash flow conversion efficiency of Baotou Dongbao Bio-Tech Co Ltd from 2008 to 2025. View 300239 share price today for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥1.72 Billion ≈ $252.16 Million	CN¥105.92 Million ≈ $15.50 Million	0.061x	+54.67%
2024-12-31	CN¥1.74 Billion ≈ $254.53 Million	CN¥69.13 Million ≈ $10.12 Million	0.040x	-62.26%
2023-12-31	CN¥1.89 Billion ≈ $277.03 Million	CN¥199.39 Million ≈ $29.18 Million	0.105x	-5.32%
2022-12-31	CN¥1.76 Billion ≈ $256.94 Million	CN¥195.32 Million ≈ $28.58 Million	0.111x	+246.38%
2021-12-31	CN¥1.60 Billion ≈ $234.67 Million	CN¥51.50 Million ≈ $7.54 Million	0.032x	-49.22%
2020-12-31	CN¥998.18 Million ≈ $146.07 Million	CN¥63.13 Million ≈ $9.24 Million	0.063x	+250.67%
2019-12-31	CN¥991.86 Million ≈ $145.14 Million	CN¥-41.63 Million ≈ $-6.09 Million	-0.042x	-152.53%
2018-12-31	CN¥750.88 Million ≈ $109.88 Million	CN¥60.00 Million ≈ $8.78 Million	0.080x	+1970.83%
2017-12-31	CN¥729.75 Million ≈ $106.79 Million	CN¥-3.12 Million ≈ $-456.11K	-0.004x	-107.57%
2016-12-31	CN¥718.86 Million ≈ $105.19 Million	CN¥40.54 Million ≈ $5.93 Million	0.056x	-12.57%
2015-12-31	CN¥706.55 Million ≈ $103.39 Million	CN¥45.57 Million ≈ $6.67 Million	0.065x	+279.51%
2014-12-31	CN¥340.56 Million ≈ $49.83 Million	CN¥-12.24 Million ≈ $-1.79 Million	-0.036x	-239.04%
2013-12-31	CN¥351.47 Million ≈ $51.43 Million	CN¥9.08 Million ≈ $1.33 Million	0.026x	+53.46%
2012-12-31	CN¥324.03 Million ≈ $47.42 Million	CN¥5.46 Million ≈ $798.48K	0.017x	-79.42%
2011-12-31	CN¥295.99 Million ≈ $43.31 Million	CN¥24.22 Million ≈ $3.54 Million	0.082x	-15.71%
2010-12-31	CN¥122.44 Million ≈ $17.92 Million	CN¥11.88 Million ≈ $1.74 Million	0.097x	-29.35%
2009-12-31	CN¥100.65 Million ≈ $14.73 Million	CN¥13.83 Million ≈ $2.02 Million	0.137x	+422.49%
2008-12-31	CN¥97.87 Million ≈ $14.32 Million	CN¥-4.17 Million ≈ $-610.07K	-0.043x	--

About Baotou Dongbao Bio-Tech Co Ltd

SHE:300239 China Drug Manufacturers - Specialty & Generic

Market Cap

$426.51 Million

CN¥2.91 Billion CNY

Market Cap Rank

#13185 Global

#3921 in China

Share Price

CN¥4.91

Change (1 day)

+0.20%

52-Week Range

CN¥4.52 - CN¥6.63

All Time High

CN¥9.53